Health Care M&A Weekly Deals, The Week Ending September 22, 2017

by | Sep 22, 2017 7:17 pm | Healthcare Market Updates

We hope you are enjoying your membership to HealthCareMandA.com. This Health Care M&A Weekly chart below is a selection of transactions announced during the prior week(s). The deals presented here are further elaborated in the monthly newsletter, Health Care M&A News, and in the quarterly report.

This information also appears in our online database, Deal Search Online. Visit www.dealsearchonline.com to open a guest account and begin your search.

Biotechnology
Acquirer Target Price
Mitobridge, Inc. License to NAD+ intellectual property N/A
Pluriomics B.V. Axiogenesis AG N/A
InDevR, Inc. License to monoclonal antibodies N/A
STEMCELL Technologies Inc. License to EpiX™ technology N/A
Taiho Pharmaceutical Co. Ltd. License to Arcus’ product candidates $35 million
Provention Bio, Inc. License to PRV-6527 and PRV-300 N/A

Laboratories, MRI and Dialysis
Acquirer Target Price
Avista Capital Partners Miraca Life Sciences N/A

Long-Term Care
Acquirer Target Price
Bridge Investment Group Symphony at Oak Lawn $29.3 million
Welltower Inc. The Orchard Katy N/A

Managed Care
Acquirer Target Price
Anthem, Inc. HealthSun N/A

Pharmaceuticals
Acquirer Target Price
Foundation Consumer Healthcare, LLC Rights to Teva’s emergency contraception brands $675 million
CVC Capital Partners Fund VI Teva’s women’s health products $703 million

Physician Medical Groups
Acquirer Target Price
CRH Medical Corporation GI anesthesia practice in North Carolina N/A

Other Services
Acquirer Target Price
Catalent, Inc. Cook Pharmica LLC $950 million
Inland Private Capital Corporation Kleiman Evangelista Eye Center N/A

Submit a Comment

Your email address will not be published. Required fields are marked *